v3.26.1
CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning Balance at Dec. 31, 2024 $ 407,976 $ 7 $ 951,519 $ 674 $ (544,224)
Beginning Balance, Shares at Dec. 31, 2024   70,645,139      
Issuance of common stock upon vesting of restricted stock units, Shares   312,415      
Share-based compensation expense 2,834   2,834    
Unrealized loss on investments (22)     (22)  
Net loss (31,983)       (31,983)
Ending Balance at Mar. 31, 2025 378,805 $ 7 954,353 652 (576,207)
Ending Balance, Shares at Mar. 31, 2025   70,957,554      
Beginning Balance at Dec. 31, 2024 407,976 $ 7 951,519 674 (544,224)
Beginning Balance, Shares at Dec. 31, 2024   70,645,139      
Net loss (54,960)        
Ending Balance at Jun. 30, 2025 357,668 $ 7 956,483 362 (599,184)
Ending Balance, Shares at Jun. 30, 2025   71,024,512      
Beginning Balance at Mar. 31, 2025 $ 378,805 $ 7 $ 954,353 652 (576,207)
Beginning Balance, Shares at Mar. 31, 2025   70,957,554      
Issuance of common stock upon vesting of restricted stock units, Shares   14,827      
Common stock issued under employee stock purchase plan, Shares 77,000 52,131 77,000    
Share-based compensation expense $ 2,053   $ 2,053    
Unrealized loss on investments (290)     (290)  
Net loss (22,977)       (22,977)
Ending Balance at Jun. 30, 2025 357,668 $ 7 956,483 362 (599,184)
Ending Balance, Shares at Jun. 30, 2025   71,024,512      
Beginning Balance at Dec. 31, 2025 312,325 $ 7 960,219 407 (648,308)
Beginning Balance, Shares at Dec. 31, 2025   71,078,531      
Issuance of common stock upon exercise of stock options 6   6    
Issuance of common stock upon exercise of stock options, Shares   3,719      
Issuance of common stock upon vesting of restricted stock units, Shares   208,240      
Share-based compensation expense 1,898   1,898    
Unrealized loss on investments (537)     (537)  
Net loss (27,832)       (27,832)
Ending Balance at Mar. 31, 2026 285,860 $ 7 962,123 (130) (676,140)
Ending Balance, Shares at Mar. 31, 2026   71,290,490      
Beginning Balance at Dec. 31, 2025 312,325 $ 7 960,219 407 (648,308)
Beginning Balance, Shares at Dec. 31, 2025   71,078,531      
Net loss (68,200)        
Ending Balance at Jun. 30, 2026 247,738 $ 7 964,664 (425) (716,508)
Ending Balance, Shares at Jun. 30, 2026   71,622,221      
Beginning Balance at Mar. 31, 2026 285,860 $ 7 962,123 (130) (676,140)
Beginning Balance, Shares at Mar. 31, 2026   71,290,490      
Issuance of common stock upon exercise of stock options $ 603   $ 603    
Issuance of common stock upon exercise of stock options, Shares   274,306      
Issuance of common stock upon vesting of restricted stock units, Shares   10,570      
Common stock issued under employee stock purchase plan, Shares 73,000 46,855 73,000    
Share-based compensation expense $ 1,865   $ 1,865    
Unrealized loss on investments (295)     (295)  
Net loss (40,368)       (40,368)
Ending Balance at Jun. 30, 2026 $ 247,738 $ 7 $ 964,664 $ (425) $ (716,508)
Ending Balance, Shares at Jun. 30, 2026   71,622,221